✦ LIBER ✦

Clinical Safety of Licorice Flavonoid Oil (LFO) and Pharmacokinetics of Glabridin in Healthy Humans

✍ Scribed by Aoki, Fumiki; Nakagawa, Kaku; Kitano, Mitsuaki; Ikematsu, Hideyuki; Nakamura, Kenjirou; Yokota, Shinichi; Tominaga, Yuji; Arai, Naoki; Mae, Tatsumasa

Book ID: 126958015
Publisher: Informa UK (Taylor & Francis)
Year: 2007
Tongue: English
Weight: 395 KB
Volume: 26
Category: Article
ISSN: 0731-5724
DOI: 10.1080/07315724.2007.10719603

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, safety and immunomodul

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

✍ Granowitz, Eric V.; Porat, Reuven; Mier, James W.; Pribble, John P.; Stiles, Dav 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 877 KB

Safety, tolerability, and pharmacokineti

Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers

✍ Choy, Gavin; Joshi-Hangal, Rajashree; Oganesian, Aram; Fine, Gil; Rasmussen, Sco 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 409 KB

No clinically relevant pharmacokinetic a

No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers

✍ Rebecca Spence; Arun Mandagere; Brooke Harrison; Christopher Dufton; Ramesh Boin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Ambrisentan is a nonsulfonamide, ET(A)-selective endothelin receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension (PAH), and tadalafil is a phosphodiesterase type 5 (PDE-5) inhibitor under investigation for treatment of PAH. Due to the potential combination use, the

Single-Dose, First-in-Human Study of AMG

Single-Dose, First-in-Human Study of AMG 853: Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Adults

✍ Banfield, C.; Parnes, J.; Emery, M.; Ni, L.; Zhang, N.; Hodsman, P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Development of atropine sulphate nasal d

Development of atropine sulphate nasal drops and its pharmacokinetic and safety evaluation in healthy human volunteers

✍ Sheetal Rajpal; Gaurav Mittal; Ruchi Sachdeva; Mitrabasu Chhillar; Rashid Ali; S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Clinical Safety, Tolerability, Pharmacok

Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers

✍ Ogata, Koichiro; Mendell-Harary, Jeanne; Tachibana, Masaya; Masumoto, Hiroshi; O 📂 Article 📅 2010 🏛 Sage Publications 🌐 English ⚖ 344 KB